Document Detail


ACOG Committee Opinion. Number 283, May 2003. New U.S. Food and Drug Administration labeling on Cytotec (misoprostol) use and pregnancy.
MedLine Citation:
PMID:  12738178     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
On April 17, 2002, the U.S. Food and Drug Administration approved a new label for the use of Cytotec (misoprostol) during pregnancy. The new labeling does not contain claims regarding the efficacy and/or safety of Cytotec when it is used for cervical ripening for the induction of labor nor does it stipulate doses or dosing intervals. Therefore, the Committee on Obstetric Practice reminds Fellows that this agent should be used as previously recommended.
Authors:
Related Documents :
22723688 - Medial prefrontal cortex neuronal activation and synaptic alterations after stress-indu...
9161148 - Hershey foods corporation: a case study in managed dental care.
19843198 - The acceptability to stakeholders of mandatory nutritional labelling in france and the ...
2378288 - Dietary restraint and eating behavior in the natural environment.
16903038 - Overwinter mass loss of snowshoe hares in the yukon: starvation, stress, adaptation or ...
24768728 - Formulating slms as oral pulsatile system for potential delivery of melatonin to paedia...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  101     ISSN:  0029-7844     ISO Abbreviation:  Obstet Gynecol     Publication Date:  2003 May 
Date Detail:
Created Date:  2003-05-09     Completed Date:  2003-06-03     Revised Date:  2009-10-26    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1049-50     Citation Subset:  AIM; IM    
Affiliation:
The American College of Obstetricians and Gynecologists, Washington DC 20092-6920, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Drug Labeling*
Female
Humans
Misoprostol* / therapeutic use
Pregnancy / drug effects*
United States
United States Food and Drug Administration*
Chemical
Reg. No./Substance:
59122-46-2/Misoprostol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diagnostic performance of intracardiac echogenic foci for Down syndrome: a meta-analysis.
Next Document:  Indole-3-carbinol and 3,3'-diindolylmethane induce apoptosis in human prostate cancer cells.